Gregory D. Plowman
Directeur/Bestuurslid bij New York Biotechnology Association, Inc.
Oorsprong van het eerstegraads netwerk van Gregory D. Plowman
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY.
19
| Non-Profit Organization | Miscellaneous Commercial Services | 19 |
AurKa Pharma, Inc.
 AurKa Pharma, Inc. BiotechnologyHealth Technology AurKa Pharma, Inc. develops medication for cancer treatment. The company was founded by Caroline Fortier and is headquartered in Montreal, Canada.
3
| Subsidiary | Biotechnology | 3 |
Acanthas Pharma, Inc.
 Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Acanthas Pharma, Inc. manufactures pharmaceutical products. The company is headquartered in Montréal, Canada.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gregory D. Plowman via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Charles River Laboratories, Inc.
 Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
| RAPID MICRO BIOSYSTEMS, INC. | Industrial Machinery | Director/Board Member | |
| ENUMERAL BIOMEDICAL HOLDINGS INC | Biotechnology | Director/Board Member Founder | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Chief Tech/Sci/R&D Officer Graduate Degree | |
CDP Capital Private Equity
 CDP Capital Private Equity Investment ManagersFinance CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London. | Investment Managers | President | |
| Queen's University | College/University | Graduate Degree | |
Thompson Street Capital Managers LLC
 Thompson Street Capital Managers LLC Investment ManagersFinance Thompson Street Capital Managers LLC (Thompson Street Capital) is a private equity subsidiary of Thompson Street Capital Partners LLC, founded in 2000 by James A. Cooper and Peter Finley. The firm is headquartered in St. Louis, Missouri. | Investment Managers | Consultant / Advisor | |
Taconic Biosciences, Inc.
 Taconic Biosciences, Inc. Agricultural Commodities/MillingProcess Industries Taconic Biosciences, Inc. provides research rodents and related products and services. It offers monoclonal antibody production, drug safety testing and other services. The firm also provides contract breeding solutions, animal models, Taconic transgenic exchange, custom model generation, contract research solutions, and research services. The company was founded by Robert K. Phelan in 1949 and is headquartered in Rensselaer, NY. | Agricultural Commodities/Milling | Chief Executive Officer | |
| Hofstra University | College/University | Undergraduate Degree | |
| Suffolk University | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| New York University | College/University | Graduate Degree Undergraduate Degree | |
| University of Ottawa | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Doctorate Degree | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Director/Board Member | |
LymphoSign, Inc.
 LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Biotechnology | Director/Board Member | |
| INTRA-CELLULAR THERAPIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Esperas Pharma Inc.
 Esperas Pharma Inc. Pharmaceuticals: MajorHealth Technology Esperas Pharma, Inc. manufactures and develops pharmaceutical products. The firm is created to develop one compound to proof-of-concept. It plans to develop, to proof-of-concept, a compound originally discovered through one of Lilly’s research and development programs, with the potential to treat certain types of cancers including triple negative breast cancer. The company was founded in 2015 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ITI, Inc. (New York) | Director/Board Member Director/Board Member | ||
| TVM Life Science Management, Inc. | Investment Managers | Corporate Officer/Principal | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| American Red Cross Biomedical Services | Public Communications Contact | ||
| Verax Corp. | Miscellaneous | Sales & Marketing | |
| ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
LikeMinds, Inc. (Massachusetts)
 LikeMinds, Inc. (Massachusetts) Personnel ServicesCommercial Services LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA. | Personnel Services | Director/Board Member | |
Ixchelsis Ltd.
 Ixchelsis Ltd. BiotechnologyHealth Technology Ixchelsis Ltd. develops oxytocin receptor antagonist for the treatment of premature ejaculation. It operates as a biotechnology company. The firm's product in pipeline IX-01 treats the male sexual health indication and premature ejaculation. The company was founded on July 27, 2011 by Gary John Muirhead, Lizbeth Anne Littlewood, Ian Howard Osterloh and Karl Richard Gibson and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Director/Board Member | |
Real Chemistry, Inc.
 Real Chemistry, Inc. Data Processing ServicesTechnology Services Real Chemistry, Inc. is an end-to-end healthcare experience group that leverages advanced AI-powered insights, diverse expertise, and customer-centric ideas to transform the healthcare industry. Real Chemistry is based in New York, NY and has subsidiaries in Canada, United Kingdom, and United States. The company helps healthcare professionals better understand, reach, and engage patients, while creating healthcare experiences that span diagnosis to adherence. The company was founded in 2001 by Jim Weiss. Shankar Narayanan has been the CEO of the company since 2022. | Data Processing Services | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 26 |
| Canada | 18 |
| Zweden | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 17 |
| Consumer Services | 9 |
| Finance | 8 |
| Commercial Services | 7 |
| Producer Manufacturing | 2 |
Operationeel
| Director/Board Member | 115 |
| Corporate Officer/Principal | 30 |
| Chief Executive Officer | 15 |
| Undergraduate Degree | 14 |
| Chairman | 12 |
Sterkste connecties
| Insiders | |
|---|---|
| Joel Marcus | 57 |
| Luc Marengère | 31 |
| Robert van Nostrand | 22 |
| Aaron Etra | 16 |
| Arthur H. Tinkelenberg | 12 |
| Caroline Fortier | 9 |
| Todd F. Little | 6 |
| Hala Mirza | 6 |
| Ellen Corenswet | 6 |
| Robert A. Cantone | 5 |
| Edgar H. Haug | 5 |
| Peter G. Robinson | 4 |
| Barry W. Weiner | 4 |
| Joel I. Papernik | 4 |
| Richard Catalano | 4 |
- Beurs
- Insiders
- Gregory D. Plowman
- Bedrijfsconnecties
